Malignant gestational trophobalstic tumor with markedly elevated serum hCG levels and negative urine hCG level / 대한산부인과학회지
Korean Journal of Obstetrics and Gynecology
; : 1277-1283, 2007.
Article
de Ko
| WPRIM
| ID: wpr-106571
Bibliothèque responsable:
WPRO
ABSTRACT
Gestational trophoblastic disease comprises a spectrum of interrelated conditions originating from the placenta. Malignant gestational trophoblastic disease refers to lesions that have the potential for local invasion and metastasis. This compromises many histological entities including hydatidiform moles, invasive moles, gestational choriocarcinomas, and placental site trophoblastic tumors. Before the advent of sensitive assays for human chorionic gonadotropin (hCG) and efficacious chemotherapy, the morbidity and mortality from gestational trophoblastic disease were substantial. Currently, with sensitive quantitative assays for beta-hCG and current approaches to chemotherapy, most women with malignant trophoblastic disease can be cured. We present a case of malignant gestational trophobalstic tumor with serum beta-hCG concentration over 1million IU/L that metastaze to the lungs and have a hyperthyroidism, but negative urine hCG testing. We report a case with a brief review of literatures.
Mots clés
Texte intégral:
1
Indice:
WPRIM
Sujet Principal:
Placenta
/
Trophoblastes
/
Choriocarcinome
/
Mortalité
/
Tumeur trophoblastique du site d'implantation placentaire
/
Môle invasive
/
Maladie trophoblastique gestationnelle
/
Traitement médicamenteux
/
Gonadotrophine chorionique
/
Hyperthyroïdie
Type d'étude:
Prognostic_studies
Limites du sujet:
Female
/
Humans
/
Pregnancy
langue:
Ko
Texte intégral:
Korean Journal of Obstetrics and Gynecology
Année:
2007
Type:
Article